
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
EU-funded BioSupPack project turns brewery waste into bioplastics - 2
Study reveals links between global food systems, obesity, and climate change - 3
Vote In favor of Your Favored Cereal - 4
Five EU states press for windfall taxes on fossil energy sector - 5
Images of Bangladeshi motorcyclists sleeping at petrol pumps are AI-generated
Sources: IDF does not actually know how many ballistic missiles Iran has left
The Best Internet Mastering Stages for Expertise Improvement
The many ways that baking is winter therapy. With a delicious ending
Pick Your Number one sort of blossom
\Step by step instructions to Pick the Best Material Organization for Your Home\
We analyzed Philly street scenes and identified signs of gentrification using machine learning trained on longtime residents’ observations
Germany's Deutsche Welle broadcaster declared 'undesirable' in Russia
Vote In favor of Your Favored Kind Of Bites
A definitive Manual for Choosing Indoor Plants Ideal for Your Space













